Clinical Trial Update: Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP [Phase 2]

View source ↗

Summary

Phase 2 trial comparing radiotherapy plus LHRH agonist vs apalutamide in patients with biochemical recurrence after radical prostatectomy for prostate cancer; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)
• LHRH agonist (Gonadotropin-releasing hormone (GnRH) agonist)

Snippet

Sponsor: Cancer Research Antwerp | Conditions: Cancer of Prostate | Phase 2 | Status: UNKNOWN